New Cancer Gene Detection Tech Achieves High Sensitivity
Researchers developed a new nanomaterial-based technology that detects cancer mutant genes in blood with unparalleled sensitivity.
Read MorePosted by Andy Lundin | Sep 6, 2024 | Cancer |
Researchers developed a new nanomaterial-based technology that detects cancer mutant genes in blood with unparalleled sensitivity.
Read MorePosted by Andy Lundin | Sep 4, 2024 | Cancer, Histology |
A new AI model is capable of diagnosing multiple types of cancer, predicting patient survival, and identifying tumor molecular profiles.
Read MorePosted by Andy Lundin | Aug 28, 2024 | Cancer |
The FDA approved Illumina’s oncology comprehensive test as an IVD tool, along with its first two CDx indications for cancer patients.
Read MorePosted by Andy Lundin | Aug 26, 2024 | Company News, Lung Cancer |
Summary: DELFI Diagnostics appointed Thomas Russo as its new CFO to support the company’s...
Read MorePosted by Andy Lundin | Aug 23, 2024 | Digital Pathology, Lung Cancer |
A new AI-driven digital pathology platform enables fully automated, rapid, and accurate analysis of lung cancer tissue.
Read More